Ultragenyx Pharmaceutical (RARE) Treasury Shares (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) has 4 years of Treasury Shares data on file, last reported at $10.0 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 32.17% year-over-year to $10.0 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 32.17% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, up 100.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $10.0 million, up from $8.0 million in the prior quarter.
• Over the last five years, Treasury Shares for RARE reached as high as $300000.0 in Q1 2026 and fell as low as $7812.0 in Q1 2023.
• Historically, Treasury Shares has averaged $103094.8 across 4 years, with a median of $68923.0 in 2024.
• Across the five-year window, Treasury Shares jumped 835.96% in 2024 and surged 32.17% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $432000.0 in 2023, then surged by 825.93% to $4.0 million in 2024, then jumped by 100.0% to $8.0 million in 2025, then increased by 25.0% to $10.0 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $10.0 million in Q1 2026, $8.0 million in Q4 2025, and $8.0 million in Q3 2025.